Map of Earth's underworld shows hidden ‘blobs' blamed for wiping out almost all life & killing the dinosaurs
BLOB-POCALYPSE Map of Earth's underworld shows hidden 'blobs' blamed for wiping out almost all life & killing the dinosaurs
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
MYSTERIOUS 'BLOBS' lurking beneath the Earth's surface could be responsible for the cataclysmic volcanic eruptions that helped kill off the dinosaurs.
While an asteroid impact was the main force behind the demise of the dinosaurs, a chain of violent volcanic eruptions that followed the impact is also thought to have played a role.
Sign up for Scottish Sun
newsletter
Sign up
4
These so-called 'BLOBS' - which stands for big lower-mantle basal structures - lie thousands of kilometers below Earth's surface
Credit: Cucchiaro et al., Communications Earth & Environment, 2025
4
While an asteroid impact was the main force behind the demise of the dinosaurs, a chain of violent volcanic eruptions that followed the impact is also thought to have played a role
Credit: Getty
4
There are two giant 'BLOBS' that are both the size of continents hiding under the African and Pacific hemispheres, according to researchers
Credit: Cucchiaro et al., Communications Earth & Environment, 2025
Volcanic eruptions can wipe out entire cities - just look at Pompeii - and even wipe out life on Earth.
The source of these Earth-shattering eruptions can be traced back to specific features deep within Earth's underworld, called 'BLOBS', according to a new study.
These so-called 'BLOBS' - which stands for big lower-mantle basal structures - lie thousands of kilometers below Earth's surface.
And they move just like the tectonic plates above them.
There are two giant 'BLOBS' that are both the size of continents hiding under the African and Pacific hemispheres, researchers said.
Volcanologist Annalise Cucchiaro from the University of Wollongong in Australia, discovered these 'BLOBS' with her colleagues.
They say these deep Earth structures have a direct influence on volcanic activity above ground.
Giant volcanic eruptions occur when deep mantle plumes - scorching columns of rock - rise from nearly 3,000 kilometers below the surface.
Analysing three different datasets on large volcanic eruptions that occurred around 300 million years ago, the researchers concluded that the 'BLOBS' are the source of these plumes.
"This work highlights the importance of mantle plumes in acting as 'magma highways' to the surface, creating these giant eruptions," Cucchiaro said in a statement.
World's smallest volcano found by locals after bursting from ground in Peru
"It also shows that these plumes move along with their source, the BLOBS."
Although some mysteries remain - like whether the BLOBS are fixed in place or if they travel across the underworld.
"This research cracks open one of the questions that has long plagued scientists – are the BLOBS stationary or mobile and how do they relate to giant volcanic explosions – so it is a thrill to finally [be able] to unravel these mysteries," added geoscientist Nicholas Flament.
What the new research suggests is that they are part of a dynamic system that has direct repercussions for all living things above ground.
"We used statistics to show that the locations of past giant volcanic eruptions are significantly related to the mantle plumes predicted by our models," Cucchiaro and Flament wrote in The Conversation.
"This is encouraging, as it suggests that the simulations predict mantle plumes in places and at times generally consistent with the geologic record."
With all the devastation volcanic eruptions can cause, it is important to know what causes them to blow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
a day ago
- Metro
Common drug may speed up ageing, study finds
Hiyah Zaidi Published July 17, 2025 10:27am Link is copied Comments Taking a common drug which acts on the nervous system could be leading to faster ageing in older adults, a new study says. Published in the journal JAMA Open Network, the researchers concluded that a high exposure to anticholinergic drugs - used in flu medicine, and to relieve motion sickness and histamine reactions - could lead to a faster decline in physical performance in older age (Picture: Getty) Anticholinergic drugs are also used to treat chronic obstructive pulmonary disease, bladder illnesses and Parkinson's. They work by blocking the action of the nerve-to-nerve signalling molecule acetylcholine, which plays a key role in the functioning of the nervous system. They affect several major bodily functions. However, by discontinuing use, the sedative and cognitive adverse effects can be reversed (Picture: Getty) Anticholinergics are common. They are used to reduce cold and flu symptoms, (diphenhydramine/Benadryl), relieve motion sickness and histamine reactions (promethazine/Phenergan) and relax the bladder to limit needing the toilet all the time (oxybutynin/Ditropan). They're also used to relieve muscle stiffness in Parkinson's disease sufferers and even used as a common sleep aid (Picture: Getty) Anticholinergics can be used to dull an important neurotransmitter for thinking, muscle control and memory, known as acetylcholine. But past studies have revealed that by dulling it, a person can experience confusion, drowsiness, dizziness and weakness, and over time, these symptoms can turn into chronic issues with memory and movement. The latest study wanted to look at the effects of constant exposure to the drugs over a decade – while looking at intensity, duration and timing of past intake (Picture: Getty) The researchers looked at the changes in walking speed and grip strength in over 4,000 older adults over time and compared this with their exposure to anticholinergic medications based on data collected from February 1994 to March 2020. Their study focused on older people, so the average baseline for the men and women was 74.3 years, with follow-up assessments around eight years later (Picture: Getty) They found that while grip strength appeared unaffected, a higher exposure to anticholinergics was linked to a greater decline in walking speed, especially in people who had taken these drugs in what would be deemed clinically conventional, so more than 1,096 daily doses over 10 years. Frailty and changes in balance and gait are linked to multiple measures of poor health outcomes, including disability and mortality. However, they also found that those who met that 1,096 daily-dose threshold in the previous six years were found to have a much higher likelihood of weakened grip as well as slower walking pace (Picture: Getty) The researchers do not advise steering clear of anticholinergics completely, but ask people to be mindful of long-term use. They said: 'Anticholinergics are associated with numerous adverse outcomes in older adults; therefore, it is essential for clinicians to avoid their use when possible, prescribe the lowest effective dose, and periodically reevaluate patients to identify de-prescribing opportunities to minimize potential harms' (Picture: Getty) Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
Scottish Sun
a day ago
- Scottish Sun
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. Sign up for Scottish Sun newsletter Sign up 1 Alzheimer's was reversed in mice Credit: Alamy The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' Common painkiller used for back pain ups risk of dementia by 29%, scientists warn She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine.
Scottish Sun
a day ago
- Scottish Sun
Common sweetener in fizzy drinks and yoghurt ‘can kill off the deadliest cancer'
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A COMMON sugar substitute used in fizzy drinks, yoghurts and gum could be used to combat one of the deadliest kinds of cancer. Researchers fermented the zero calorie sweetener and tested it against pancreatic cancer - finding that it killed off malignant cells but didn't harm healthy ones. Sign up for Scottish Sun newsletter Sign up 2 Stevia extract could be used to help fight pancreatic cancer, researchers suggested Credit: Getty 2 They tested fermented extracts against pancreatic cancer cells in a lab dish Credit: Getty Stevia is a shrub-like herb used to sweeten drinks and desserts instead of sugar, which can also be bought as powder or tablets. Previous research has suggested that stevia leaf extracts could have potential "anticancer effects". But isolating specific substances within the herb that could help protect against cancer and using them has remained challenging. Researchers from Hiroshima University suggested fermenting stevia with bacteria can structurally change the extract and produce bioactive metabolites - compounds that can impact living organisms. Study author Masanori Sugiyama, a professor in the Department of Probiotic Science for Preventive Medicine, said fermentation - or "microbial bio-transformation" - could "enhance the pharmacological efficacy of natural plant extracts" like stevia. The team tested their theory out against pancreatic cancer cells. "Pancreatic cancer is a highly malignant tumour of the digestive system with a poor prognosis," co-author Prof Narandalai Danshiitsoodol said. "Globally, the incidence and mortality rates of pancreatic cancer continue to rise, with a five-year survival rate of less than 10 per cent. "The primary reason pancreatic cancer is considered one of the deadliest cancers is its subtle, insidious onset, with most patients being diagnosed at an advanced stage and missing the optimal treatment window. "Furthermore, pancreatic cancer is highly invasive and prone to metastasis, showing significant resistance to existing treatments such as surgery, radiotherapy, and chemotherapy, resulting in very limited therapeutic efficacy. The most common symptoms of pancreatic cancer - as patients share their stories "Therefore, there is an urgent need to identify new and effective anticancer compounds, particularly those derived from medicinal plants." Researchers used lactic acid bacteria to ferment stevia extracts. They isolated over 1200 strains from fruits, vegetables, flowers, and medicinal plants and evaluated their health benefits. They finally landed on Lactobacillus plantarum SN13T strain (FSLE) derived from banana leaves "to enhance the antioxidant and anticancer activities of stevia leaf extract through fermentation". They tested fermented and non-fermented stevia extracts against pancreatic cancer cells in lab dishes. Fermented stevia killed pancreatic cancer cells more efficiently than the non-fermented extract, the study published in the International Journal of Molecular Sciences found. This suggested that "the fermentation process enhances the bioactivity of the [stevia] extract", Prof Sugiyama said. Researchers tested out different fermentation levels to see which was most effective against cancer cells. Symptoms of pancreatic cancer PANCREATIC cancer doesn't always cause symptoms in its early stages. As the cancer grows and you do begin to show signs, these may come and go and be unspecific, making it hard to diagnose, according to Pancreatic Cancer UK. Common symptoms include: Indigestion - a painful, burning feeling in your chest with an unpleasant taste in your mouth Tummy or back pain - it may start as general discomfort or tenderness in the tummy area and spread to the back, which get worse lying down and feel better is you sit forward Diarrhoea and constipation - see a GP if you have runny poos for more than seven days, especially if you've lost weight as well Steatorrhoea - pale, oily poo that's bulky, smells horrible and floats, making it hard to flush Losing a lot of weight without meaning to Jaundice - yellow skin and eyes, as well as dark pee, pale poo and itchy skin Lower concentrations didn't kill cancer cells immediately, but they slowed their growth. Healthy kidney cells were mostly unaffected by the stevia extracts. Researchers plan to study how fermented stevia affects cancer in mice next, to see how various dosages will work in living organisms. 'The present study has substantially enhanced our understanding of the mechanism of action of the Lactobacillus plantarum SN13T strain in the fermentation of herbal extracts, while also offering a valuable research perspective on the potential application of probiotics as natural anti-tumour agents,' Prof Danshiitsoodol said. In the UK, about 10,800 people are diagnosed with pancreatic cancer each year and 9,600 pass away from it, according to Cancer Research UK. It's the fifth most common cause of cancer death. Since the early 1990s, pancreatic cancer incidence rates have increased by 18 per cent in the UK. The disease is often diagnosed at a late stage because it frequently lacks noticeable symptoms in the early stages. Surgery, chemotherapy and radiation can help extend patients' lives. A blood test to pick up early signs of pancreatic cancer is being trialled in patients with a recent diagnosis of type 2 diabetes - a known risk factor for the disease. Meanwhile, researchers at Case Western Reserve University and Cleveland Clinic have developed a new type of jab to fight pancreatic cancer.
